Search

Your search keyword '"Lievre A"' showing total 2,059 results

Search Constraints

Start Over You searched for: Author "Lievre A" Remove constraint Author: "Lievre A"
2,059 results on '"Lievre A"'

Search Results

1. Enabling Unit Proofing for Software Implementation Verification

3. Preserved Ratio Impaired Spirometry in US Primary Care Patients Diagnosed with Chronic Obstructive Pulmonary Disease

4. Numerical data for modelling pavement deflection behaviour under the TSDLicense : etalab 2.0

5. A Decision Tree Approach to Predict the Online Information Search Performance of 8-13 Year Old Students in French-Speaking Belgium

6. The Association Between Short-Acting β2-Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia

7. Collaborative Innovations in Childhood Cancer Therapies

8. SUNLAND: a randomized, double-blinded phase II GERCOR trial of sunitinib versus placebo and lanreotide in patients with advanced progressive midgut neuroendocrine tumors

9. EFFECTS OF A DISTANCE LEARNING COURSE FOR TEACHERS ON PROPORTIONALITY ON THEIR PERCEPTION OF SELF-EFFICACY

12. Immunovirological status in people with perinatal and adult-acquired HIV-1 infection: a multi-cohort analysis from France

13. Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT)

14. Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies

15. Should we screen for colorectal cancer in people aged 75 and over? A systematic review - collaborative work of the French geriatric oncology society (SOFOG) and the French federation of digestive oncology (FFCD)

21. Panitumumab in combination with chemoradiotherapy for the treatment of locally-advanced anal canal carcinoma: Results of the FFCD 0904 phase II trial

22. Classification of PRSS1 variants responsible for chronic pancreatitis: An expert perspective from the Franco-Chinese GREPAN Study Group

24. Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASE

25. A Study of the Challenges of Eye Tracking Systems and Gaze Interaction for Individuals with Motor Disabilities

26. Enabling Collaborative Situations in 4.0 Industry: Multiple Case Study

27. The PRSS3P2 and TRY7 deletion copy number variant modifies risk for chronic pancreatitis

30. COPD Population in US Primary Care: Data From the Optimum Patient Care DARTNet Research Database and the Advancing the Patient Experience in COPD Registry

31. United States Centers for Disease Control and Prevention support for influenza surveillance, 2013-2021/Aide apportee par les Centers for Disease Control and Prevention des Etats-Unis d'Amerique dans la surveillance des grippes, 2013-2021/Apoyo de los Centros para el Control y la Prevencion de Enfermedades de Estados Unidos a la vigilancia de la gripe, 2013-2021

32. Lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours: An international double-blind, placebo-controlled randomised phase II trial – Prodige 31 REMINET: An FFCD study

33. Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis

35. SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer

36. Identification and Characterization of Innate Immunity in Actinidia melanandra in Response to Pseudomonas syringae pv. actinidiae.

37. MiR-31-3p do not predict anti-EGFR efficacy in first-line therapy of RAS wild-type metastatic right-sided colon cancer

41. Defining a Severe Asthma Super-Responder: Findings from a Delphi Process

44. Pembrolizumab with Capox Bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: The FFCD 1703-POCHI trial

45. Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

48. Health-related quality of life in locally advanced hepatocellular carcinoma treated by either radioembolisation or sorafenib (SARAH trial)

49. Cost-Utility Analysis of Transarterial Radioembolization With Yttrium-90 Resin Microspheres Compared With Sorafenib in Locally Advanced and Inoperable Hepatocellular Carcinoma

50. What is the optimal treatment for T1N0 anal squamous cell carcinoma? Analysis of current practices in the prospective French FFCD ANABASE cohort

Catalog

Books, media, physical & digital resources